Hideya Yaginuma
Osaka University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hideya Yaginuma.
Japanese Journal of Medical Mycology | 1989
Tatsuya Morita; Yasuhiro Ishizuka; Toshikazu Arioka; Yasuo Mito; Hideya Yaginuma; Yoshinori Nozawa
GBR-14206, a new imidazole derivative, has been evaluated against systemic infection with Candida albicans in normal and immunocompromised mice. The therapeutic effect of GBR-14206 (as a lipid emulsion) given intravenously to mice infected systemically with C. albicans was superior to that of miconazole. GBR-14206 also showed a candicidal effect in the blood stream at the therapeutic dose. In addition, GBR-14206 inhibited the hyphal growth (yeast to hyphal transformation) in Eagles minimum essential medium and methionine synthetic medium at the respective concentrations of 0.20 and 0.05μg/ml, which were approximately 3 to 7 times more active than miconazole.These properties suggested that GBR-14206 may be useful for the therapy of systemic candidiasis in human.
Japanese Journal of Medical Mycology | 1989
Tatsuya Morita; Yasuhiro Ishizuka; Hideya Yaginuma; Mitsuko Matsuda; Yoshinori Nozawa
The antifungal activity of GBR-14206, a new imidazole derivative, was evaluated in comparison with those of clotrimazole (CTZ) and miconazole (MCZ) using an agar dilution procedure.GBR-14206 showed a potent activity against a wide range of pathogenic fungi including those associated with deep-seated and subcutaneous mycosis; it inhibited some standard strains of C. albicans at concentrations of 12.5μg/ml or less. Similarly, clinical isolates from various mycoses were also highly susceptible to GBR-14206 (MIC range; 0.0125-6.25μg/ml). The most striking activity of GBR-14206 was displayed against Cryptococcus neoformans (MIC range; 0.0125-0.05μg/ml), which was far superior to MCZ and CTZ. Against C. albicans, Trichophyton spp., and Microsporum spp., the activity of GBR-14206 was more moderate than MCZ and CTZ. Against Sporothrix schenckii, GBR-14206 had a lower mean MIC value than that of CTZ and was similar to MCZ. On the other hand, against Aspergillus spp., GBR-14206 was less effective than MCZ and CTZ. Fungal susceptibility of GBR-14206 tended to be enhanced with increasing medium pH. The activity was also lowered by addition of calf serum.
Chemical & Pharmaceutical Bulletin | 1981
Hideya Yaginuma; Tohru Nakata; Harumasa Toya; Teruo Murakami; Masaru Yamazaki; Akira Kamada
Chemical & Pharmaceutical Bulletin | 1989
Kohji Ozeki; Teru Ichikawa; Hiroyuki Takehara; Kenjiro Tanimura; Makoto Sato; Hideya Yaginuma
Archive | 1989
Teru Ichikawa; Yasuhiro Ishizuka; Toshiaki Kamisaki; Koji Kosegi; Masahiko Oki; Masahiro Sawada; Hiroshi Shimamura; Hideya Yaginuma
Chemical & Pharmaceutical Bulletin | 1982
Toshiyasu Matsuo; Yoshitsugu Tsukamoto; Takashi Takagi; Hideya Yaginuma
Archive | 1989
Yoshio Asaumi; Yasuhiro Ishizuka; Koji Kosegi; Keiji Uenishi; Hideya Yaginuma
Chemical & Pharmaceutical Bulletin | 1984
Masaru Yamazaki; Yoko Ito; Takumi Suzuka; Hideya Yaginuma; Soichi Itoh; Akira Kamada; Yoshimasa Orita; Hajime Nakahama; Takeshi Nakanishi; Akio Ando
Chemical & Pharmaceutical Bulletin | 1982
Hideya Yaginuma; Yutaka Kohno; Soichi Itoh; Kazuyoshi Kubo; Masaru Yamazaki; Akira Kamada; Hajime Shimazu; Toshiyasu Matsuo
Archive | 1988
Koji Kosegi; Makoto Sato; Zenji Tsukamoto; Hideya Yaginuma